2019 annual financial data
TScan Therapeutics 2019 Operating margin
TScan Therapeutics 2019 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -14,210,000 USD and net income was -13,658,000 USD.
Operating cash flow was -12,522,000 USD.
Get free TScan Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -14,210,000 USD
- Net income
- -13,658,000 USD
- Operating cash flow
- -12,522,000 USD